vimarsana.com
Home
Live Updates
Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines : vimarsana.com
Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines
/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced the...
Related Keywords
Boston
,
Massachusetts
,
United States
,
Harvard University
,
Joseph Mcdonald
,
Carll Gordon
,
Carl Gordon
,
Charles Baum
,
Jill Carroll
,
Stephen Soisson
,
Bristol Myers Squibb
,
Davidl Pompliano
,
Natalie Dales
,
Shifeng Pan
,
Valerie Odegard
,
Robert Abraham
,
Garyd Glick
,
Damon Runyon Walter Winchell Cancer Research
,
Genomics Institute Of The Novartis Research Foundation
,
Novartis
,
Pfizer
,
Chemistry At Harvard University
,
University Of Pittsburgh
,
Rockefeller University
,
Computational Chemistry At Carnegie Mellon University
,
Johns Hopkins School Of Medicine
,
York University
,
Mcdonald
,
Structural Protein Sciences At Merck Research Laboratories
,
Molecular Biology At Harvard University
,
Columbia University
,
Roswell Park Memorial Institute
,
Millennium Pharmaceuticals
,
University Of Wisconsin
,
Stanford University
,
Orbimed Advisors
,
Capital Management
,
Foresite Capital
,
Woodline Partners
,
Logos Capital
,
Colt Ventures
,
Creacion Ventures
,
Managing Partner
,
Chief Executive Officer
,
Norganic Chemistry
,
Executive Vice President
,
Cancer Biology
,
Chief Scientific Officer
,
Vividion Therapeutics
,
Senior Vice President
,
Group Head
,
Oncology Rd Group
,
Pfizer Worldwide Research
,
Drug Discovery
,
Executive Director
,
Global Discovery Chemistry Group
,
Novartis Genesis Labs
,
Chief Data Officer
,
Physics Based Simulation
,
Avila Therapeutics
,
Computational Chemistry
,
Carnegie Mellon
,
Discovery Chemistry
,
Genomics Institute
,
Novartis Research Foundation
,
New York University
,
Chief Innovation Officer
,
Revolution Medicines
,
Lodo Therapeutics
,
Worldwide Basic Head
,
Infectious Diseases
,
Vice President
,
Molecular Biology
,
Structural Biology
,
Protein Therapeutics
,
Global Head
,
Structural Chemistry
,
Structural Protein Sciences
,
Merck Research Laboratories
,
Johns Hopkins School
,
Odyssey Therapeutics
,
Mirati Therapeutics
,
vimarsana.com © 2020. All Rights Reserved.